Literature DB >> 11735260

Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice.

L Zhu1, Y Yu, B H Chua, Y S Ho, T H Kuo.   

Abstract

Our previous work in cultured cells has shown that the maintenance of mitochondrial Ca(2+) homeostasis is essential for cell survival, and that the anti-apoptotic protein Bcl-2 is able to maintain a threshold level of mitochondrial Ca(2+) by the inhibition of permeability transition. To test whether Bcl-2 also affects the mitochondrial Na(+)-Ca(2+) exchange (NCE), a major efflux pathway for mitochondrial Ca(2+), studies using transgenic mice that overexpress Bcl-2 in the heart have been performed. NCE activity was determined as the Na(+)-dependent Ca(2+) efflux in the isolated mitochondria. Overexpression of Bcl-2 led to a significant reduction of NCE activity as well as increased resistance to permeability transition in the mitochondria of transgenic heart. This was accompanied by increased matrix Ca(2+) level, enhanced formation of NADH and enhanced oxidation of pyruvate, an NAD(+)-linked substrate. Furthermore, there was induction of cellular Ca(2+) transport proteins including the Na(+)-Ca(2+) exchanger of the sarcolemma (NCX). Bcl-2 not only stimulates NCX expression in the sarcolemma but also attenuates the Na(+)-Ca(2+) exchange in the mitochondria. These results are consistent with the protection by Bcl-2 against apoptosis in heart following ischemia/reperfusion. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735260     DOI: 10.1006/jmcc.2001.1476

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  26 in total

1.  Regulation of Ca2+-induced permeability transition by Bcl-2 is antagonized by Drpl and hFis1.

Authors:  Dejuan Kong; Liping Xu; Yingjie Yu; Weijia Zhu; David W Andrews; Yisang Yoon; Tuan H Kuo
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

Review 2.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

Review 3.  Molecular identity and functional properties of the mitochondrial Na+/Ca2+ exchanger.

Authors:  Raz Palty; Michal Hershfinkel; Israel Sekler
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

4.  Apoptosis in Anthracycline Cardiomyopathy.

Authors:  Jianjian Shi; Eltyeb Abdelwahid; Lei Wei
Journal:  Curr Pediatr Rev       Date:  2011-11

Review 5.  Bcl-2 proteins and calcium signaling: complexity beneath the surface.

Authors:  T Vervliet; J B Parys; G Bultynck
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

6.  Reversal of right ventricular failure by chronic α1A-subtype adrenergic agonist therapy.

Authors:  Patrick M Cowley; Guanying Wang; Philip M Swigart; Anaha Raghunathan; Nikitha Reddy; Pranavi Dulam; David H Lovett; Paul C Simpson; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-09       Impact factor: 4.733

Review 7.  Mitochondria and mitophagy: the yin and yang of cell death control.

Authors:  Dieter A Kubli; Åsa B Gustafsson
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

Review 8.  Regulation of intracellular and mitochondrial sodium in health and disease.

Authors:  Elizabeth Murphy; David A Eisner
Journal:  Circ Res       Date:  2009-02-13       Impact factor: 17.367

9.  Activated protein C protects myocardium via activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart.

Authors:  Jia-Wang Ding; Xiao-Hong Tong; Jun Yang; Zhao-Qi Liu; Yan Zhang; Jian Yang; Song Li; Li Li
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

10.  Cardioprotection via modulation of calcium homeostasis by thiopental in hypoxia-reoxygenated neonatal rat cardiomyocytes.

Authors:  Hyun-Soo Kim; Ki-Chul Hwang; Wyun-Kon Park
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.